Ophthalmic-focused Alimera goes public, nets $68.4mm
- Controlled Release
- Site Specific
- Drug Delivery
- Implantable Devices
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.